(Q37602842)

21 August 2017

1 reference

title

Global emm type distribution of group A streptococci: systematic review and implications for vaccine development (English)

1 reference

21 August 2017

1 reference

1 reference

Jonathan R Carapetis

5

1 reference

ORCID Public Data File 2021

author name string

Andrew C Steer

1

1 reference

21 August 2017

Irwin Law

2

1 reference

21 August 2017

Laisiana Matatolu

3

1 reference

21 August 2017

Bernard W Beall

4

1 reference

21 August 2017

language of work or name

1 reference

1 October 2009

1 reference

Lancet Infectious Diseases

21 August 2017

published in

1 reference

21 August 2017

volume

9

1 reference

21 August 2017

issue

10

1 reference

21 August 2017

page(s)

611-616

1 reference

The global burden of group A streptococcal diseases

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

emm typing and validation of provisional M types for group A streptococci.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

The epidemiology of invasive group A streptococcal infection and potential vaccine implications: United States, 2000-2004

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

The epidemiology of severe Streptococcus pyogenes associated disease in Europe

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Group A Streptococcal Pharyngitis Serotype Surveillance in North America, 2000–2002

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Five-year group A streptococcal pharyngitis serotype surveillance in North America, 2000–2005

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Progress in group A streptococcal vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Safety and immunogenicity of 26-valent group a streptococcus vaccine in healthy adult volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Immunogenicity of a 26-valent group A streptococcal vaccine.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Contrasting molecular epidemiology of group A streptococci causing tropical and nontropical infections of the skin and throat

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

The contribution of specific pneumococcal serogroups to different disease manifestations: implications for conjugate vaccine formulation and use, part II.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Extension of the Lancefield classification for group A streptococci by addition of 22 new M protein gene sequence types from clinical isolates: emm103 to emm124.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Measurement of Diversity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Determining confidence intervals when measuring genetic diversity and the discriminatory abilities of typing methods for microorganisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Multiple strains of Streptococcus pyogenes in skin sores of aboriginal Australians

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Scabies and Pyoderma in Lilongwe, Malawi. Prevalence and seasonal fluctuation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Natural history of impetigo. I. Site sequence of acquisition and familial patterns of spread of cutaneous streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Epidemic nephritis at Red Lake, Minnesota

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Relationships between emm and multilocus sequence types within a global collection of Streptococcus pyogenes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Persistence of type-specific antibodies in man following infection with group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Temporal changes in streptococcal M protein types and the near-disappearance of acute rheumatic fever in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Group A streptococcus (GAS) carbohydrate as an immunogen for protection against GAS infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Protection against group A streptococcus by immunization with J8-diphtheria toxoid: contribution of J8- and diphtheria toxoid-specific antibodies to protection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Rheumatic heart disease in developing countries

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Incidence of acute rheumatic fever in the world: a systematic review of population-based studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

emm and sof gene sequence variation in relation to serological typing of opacity-factor-positive group A streptococci

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

Evolutionary Origin and Emergence of a Highly Successful Clone of Serotype M1 Group A Streptococcus Involved Multiple Horizontal Gene Transfer Events

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2809%2970178-1

7 January 2021

10.1016/S1473-3099(09)70178-1

Identifiers

DOI

1 reference

21 August 2017

1 reference